Synopex시노펙스
025320 · KOSDAQ · ₩025320 · 시노펙스
₩3,430▲ ₩85 (2.54%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩262B | ₩238B | ₩262B | ₩245B | ₩232B |
| Cost of sales | ₩212B | ₩176B | ₩200B | ₩198B | ₩197B |
| Gross profit | ₩50B | ₩62B | ₩62B | ₩46B | ₩35B |
| Operating income | ₩6.8B | ₩21B | ₩24B | ₩13B | ₩5.2B |
| Net income | ₩7.2B | ₩28B | ₩15B | ₩8.3B | ₩9.9B |
| Net income to shareholders | ₩7.4B | ₩28B | ₩15B | ₩8.5B | ₩10B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩259B | ₩235B | ₩201B | ₩215B | ₩203B |
| Current assets | ₩110B | ₩100B | ₩84B | ₩94B | ₩85B |
| Cash and equivalents | ₩51B | ₩46B | ₩26B | ₩30B | ₩14B |
| Total liabilities | ₩88B | ₩68B | ₩67B | ₩110B | ₩114B |
| Current liabilities | ₩70B | ₩60B | ₩54B | ₩96B | ₩107B |
| Borrowings | ₩44B | ₩34B | ₩29B | ₩65B | ₩64B |
| Total equity | ₩172B | ₩168B | ₩134B | ₩105B | ₩89B |
| Shareholders' equity | ₩172B | ₩168B | ₩134B | ₩105B | ₩89B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩22B | ₩37B | ₩48B | ₩29B | ₩6.8B |
| Capital spending | ₩19B | −₩25B | ₩19B | ₩13B | ₩26B |
| Free cash flow | ₩3.2B | ₩13B | ₩29B | ₩16B | −₩19B |
Consolidated where available. Amounts in won.
Also known as: Synopex / 시노펙스 / 025320 / KRX:025320
Source: KRX statistical information